Pharming Group NV
AEX:PHARM
Pharming Group NV
AEX:PHARM
Price:
1.338
EUR
-0.96%
Market Cap:
€938.5m
Relative Value
The Relative Value of one
PHARM
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 1.338 EUR,
Pharming Group NV
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PHARM Relative Value
HIDDEN
Multiples Across Competitors
PHARM Competitors Multiples
Pharming Group NV Competitors
Pharming Group NV Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NL |
|
Pharming Group NV
AEX:PHARM
|
932.2m EUR | 3 | 2 868.4 | 20.7 | 29.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
409.4B USD | 6.7 | 97.8 | 16 | 22.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.3B USD | 5.4 | 25.6 | 14.7 | 14.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.1B USD | 6.1 | 21.1 | 13.2 | 16.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.8B USD | 9.8 | 29.6 | 22.3 | 23.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81B USD | 5.6 | 18 | 13.4 | 15.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.3B AUD | 3.2 | 35.7 | 11.7 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
38.3B EUR | 10.9 | 34.9 | 37.9 | 38.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
